Functional and oncologic outcomes following radical prostatectomy play a major role in patient satisfaction after treatment. This study was designed to assess the functional and oncologic outcome after robotic assisted radical prostatectomy (RARP) in a single surgeon series of patients.
A prospectively maintained database of patients undergoing robotic radical prostatectomy in a referral academic center was queried for functional and oncologic outcome. Patients undergoing RARP between 2010 and 2013 were included. Analysis was performed with SPSS and SAS, Chi-square, Mann Whitney and t-test were used when appropriate.
Overall, 566 patients were included in the analysis. The Trifecta and Pentafecta was 73.9% and 64.1%, respectively. Patients achieving Pentafecta were younger (p<0.001), had lower PSA level (p=0.04), lower Biopsy Gleason (p<0.01), lower risk prostate cancer (p<0.01) and fewer comorbidities (p=0.03). The patients were followed up for a median of 27.4 months in Trifecta and 20.6 months in Pentafecta group. At 12-month follow up the continence and potency rate was 90.6% and 84.1%, respectively.
Although preoperative counseling for RARP surgery using Pentafecta criteria offers more precise information and reasonable expectations than using the Trifecta, further research is required to prepare a standard reporting outline.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2017 Sep 07 [Epub ahead of print]
Seyed B Jazayeri, Brittany Weissman, David B Samadi
Department of Urology, Lenox Hill Hospital, New York, NY, USA., Department of Urology, Lenox Hill Hospital, New York, NY, USA - .